Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in

  News Archive

Computerized Flexible Needles Prove Themselves in Biological Tissue
Thursday, August 27, 2015
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity
Thursday, August 27, 2015
The company enters into new agreement with Sanquin.

FDA Expands Use of Novartis Drug Promacta®
Wednesday, August 26, 2015
New oral suspension formulation, designed for younger children with rare blood disorder, is now approved.

Medivation Acquires Talazoparib Rights from BioMarin
Tuesday, August 25, 2015
Under the agreement, Medivation will be responsible for all research, development, regulatory and commercialization activities for all indications on a global basis.

AstraZeneca, Peregrine Pharmaceuticals Collaborate
Tuesday, August 25, 2015
Collaboration to Focus on Cancer Immunotherapy Combination of Peregrine's PS-Targeting Bavituximab and AstraZeneca's PD-L1 Inhibitor MEDI4736.

DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Tuesday, August 25, 2015
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.

Nottingham Gets "Grow Ahead" for New £30m Life Science Facility
Monday, August 24, 2015
Hundreds of highly skilled jobs are expected to be created and safeguarded in Nottingham with the news that work can now start on a new £30m life science building adjacent to the current BioCity site on Pennyfoot Street.

EU Approves Novartis's laBCC Therapy
Monday, August 24, 2015
Novartis has announced that the European Commission has approved Odomzo® 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) who are not amenable to curative surgery or radiation therapy.

Researchers Publish Landmark “Basket Study”
Monday, August 24, 2015
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 3795

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos